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ABSTRACT The coordination of cell-cycle events with developmental processes is essential for the
reproductive success of organisms. In Drosophila melanogaster, meiosis is tightly coupled to oocyte de-
velopment, and early embryos undergo specialized S-M mitoses that are supported by maternal products.
We previously showed that the small phosphoprotein a-endosulﬁne (Endos) is required for normal oocyte
meiotic maturation and early embryonic mitoses in Drosophila. In this study, we performed a genetic screen
for dominant enhancers of endos00003 and identiﬁed several genomic regions that, when deleted, lead to
impaired fertility of endos00003/+ heterozygous females. We uncovered matrimony (mtrm), which encodes
a Polo kinase inhibitor, as a strong dominant enhancer of endos. mtrm126 +/+ endos00003 females are sterile
because of defects in early embryonic mitoses, and this phenotype is reverted by removal of one copy of
polo. These results provide compelling genetic evidence that excessive Polo activity underlies the strong
functional interaction between endos00003 and mtrm126. Moreover, we show that endos is required for the
increased expression of Mtrm in mature oocytes, which is presumably loaded into early embryos. These
data are consistent with the model that maternal endos antagonizes Polo function in the early embryo to
ensure normal mitoses through its effects on Mtrm expression during late oogenesis. Finally, we also
identiﬁed genomic deletions that lead to loss of viability of endos00003/+ heterozygotes, consistent with
recently published studies showing that endos is required zygotically to regulate the cell cycle during
development.
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Precise control of the cell-cycle machinery at speciﬁcd e v e l o p m e n t a l
stages is crucial to ensure appropriate cellular outcomes, and research
in Drosophila melanogaster has led to signiﬁcant advances in under-
standing how this regulation is achieved (Lee and Orr-Weaver 2003).
Two relevant examples of coordination between the cell cycle and
development are found in oocyte meiotic maturation during oogenesis
and in the specialized early embryonic mitoses.
Drosophila oocytes develop within egg chambers, or follicles,
which progress through 14 stages of development within ovarian
subunits termed ovarioles (Spradling 1993). Each egg chamber is
composed of an inner germline cyst containing one oocyte and 15
supportive nurse cells and is surrounded by a monolayer of somatic
follicle cells. The oocyte initiates meiosis within very early cysts before
the acquisition of follicle cells but remains arrested in prophase of
meiosis I through most of oogenesis (Figure 1A, A9; King 1970).
During the oocyte arrest in prophase I, the egg chamber goes through
most of its development, including the dumping of nurse cell cyto-
plasmic contents into the growing oocyte during stage 11 (Spradling
1993). At stage 13, as the remaining nurse cell nuclei are gradually
Copyright © 2011 Von Stetina et al.
doi: 10.1534/g3.111.001438
Manuscript received June 28, 2011; accepted for publication October 19, 2011
This is an open-access article distributed under the terms of the Creative
Commons Attribution Unported License (http://creativecommons.org/licenses/
by/3.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
Supporting information is available online at http://www.g3journal.org/lookup/
suppl/doi:10.1534/g3.111.001438/-/DC1
1Present address: Whitehead Institute, 9 Cambridge Center, Cambridge, MA
02142.
2Corresponding author: Department of Biochemistry and Molecular Biology,
Bloomberg School of Public Health, Johns Hopkins University, 615 North Wolfe
Street, Room E8630, Baltimore, MD 21205. E-mail: dbarbosa@jhsph.edu
Volume 1 | December 2011 | 607eliminated by cell death, the fully grown oocyte undergoes meiotic
maturation, a process whereby the prophase I arrest is released and
the oocyte progresses through a second arrest in metaphase I (Figure
1B, B9,B 99). The metaphase I arrest is maintained in mature stage 14
oocytes until egg activation takes place as the oocyte passes through
the oviduct during egg laying (Horner and Wolfner 2008).
Embryonic development, which ensues after egg activation and
fertilization, relies initially on maternal RNA and proteins loaded into
the oocyte during oogenesis, independently of zygotic transcription
(Lee and Orr-Weaver 2003). Speciﬁcally, the ﬁrst 13 embryonic cell
cycles, which occur within a common, syncytial cytoplasm, are ma-
ternally controlled and represent variant mitotic cell cycles that lack
gap (G) phases and simply alternate between DNA synthesis (S) and
mitosis (M; Figure 1C, C9,C 99). Subsequently, interphase lengthens by
the addition of G2 and then G1 phases, and zygotic transcription
becomes essential (Lee and Orr-Weaver 2003).
Our previous studies uncovered critical roles for the small
phosphoprotein a-endosulﬁne (Endos) in both oocyte meiotic matu-
ration and early embryonic mitoses in Drosophila (Von Stetina et al.
2008). Oocytes in endos00003 homozygous mutant females have pro-
longed prophase I arrest and abnormal nuclear envelope breakdown,
and they fail to progress into metaphase I. In addition, the rare result-
ing embryos that initiate development display abnormal DNA and
spindle morphologies during early, maternally controlled mitoses
(Von Stetina et al. 2008). Consistent with these cell-cycle defects,
endos00003 homozygous mutant oocytes have markedly low levels of
in vivo MPM2 phosphoepitopes, which result from phosphorylation
of targets of the Polo and Cdk1 cell-cycle regulatory kinases. Paradox-
ically, however, endos00003 homozygous mutant oocytes show normal
levels of Cdk1 kinase activity in in vitro assays (Von Stetina et al.
2008). Nevertheless, recent biochemical studies using Xenopus egg
extracts showed that upon its phosphorylation by Greatwall (Gwl)
kinase, the vertebrate homolog of Endos binds to and inhibits protein
phosphatase 2A, a Cdk1 antagonist that dephosphorylates its targets
(Gharbi-Ayachi et al. 2010; Mochida et al. 2010). In addition, endos
was very recently shown to control Drosophila cell cycles through
a similar pathway (Rangone et al. 2011), potentially explaining our
paradoxical ﬁndings.
Despite these recent advances, Endos likely has additional mo-
lecular functions that contribute to cell-cycle regulation. For example,
in an in vitro screen for Endos binding partners, two speciﬁc inter-
actors were identiﬁed, including the E3 ubiquitin ligase Elgi. Interest-
ingly, although mutation of elgi results in premature meiotic
maturation, Elgi does not appear to target Endos for ubiquination
or to mediate the effects of Endos on MPM2 epitope levels (Von
Stetina et al. 2008). A complete understanding of the diverse molec-
ular roles of Endos will require the identiﬁcation of additional genes
that function with this small regulatory protein in the control of
meiotic maturation and/or early embryonic mitoses.
Here, we describe a genetic screen for dominant enhancers of
endos00003 heterozygotes. We reasoned that halving the gene dosage of
endos may sensitize females to reduced dosage of other genes func-
tioning with endos to control meiotic maturation and/or early embry-
onic mitoses, leading to reduced fertility of double heterozygous
females. We screened approximately 200 available deﬁciencies and
identiﬁed 11 genomic regions that when deleted dominantly lead to
sterility or semi-sterility of endos00003 heterozygous females. Our
screen also identiﬁed ﬁve genomic regions that result in lethality of
endos00003 heterozygotes, uncovering a zygotic function of endos. Fur-
ther analyses of an enhancer reducing the fertility of endos00003
females revealed that matrimony (mtrm), a negative regulator of Polo
kinase (Xiang et al. 2007), functions together with Endos to regulate
early embryonic mitoses. Speciﬁcally, we ﬁnd that mtrm126 +/+
endos00003 double-heterozygous females have markedly reduced fertil-
ity relative to single heterozygotes because of defects in early, mater-
nally controlled embryonic mitoses, and that this strong genetic
interaction is likely due to the fact that Endos regulates Mtrm levels
during late oogenesis.
MATERIALS AND METHODS
Drosophila culture
Drosophila stocks and crosses were maintained at 22-25  on standard
medium. ywwas used as a wild-type control. endos00003 is a strong
hypomorphic allele caused by a P element insertion in its 59 untrans-
lated region (Drummond-Barbosa and Spradling 2004; Von Stetina
et al. 2008). mtrm126 is a molecular null allele (Xiang et al. 2007); in all
crosses, mtrm126 was introduced into the analyzed genotypes via the
male because this stock is contaminated with Wolbachia, a maternally
transmitted intracellular bacterium (Serbus et al. 2008). polo16-1 is
a strong hypomorph (Donaldson et al. 2001; Roseman et al. 1995),
and the null elgi1 allele has been described (Von Stetina et al. 2008).
Deﬁciency Kit stocks were obtained from the Bloomington Dro-
sophila Stock Center (http://ﬂystocks.bio.indiana.edu/). The GFP::polo
Figure 1 Coordination between the
cell cycle and development during
meiotic maturation and early embry-
onic mitoses. (A) Stage 10 egg cham-
ber diagram, exemplifying a stage in
which the oocyte is arrested in pro-
phase I. (B) Diagram of a stage 14
oocyte, which has progressed to meta-
phase I as a result of meiotic matura-
tion. (C) Early embryo showing nuclei
that undergo mitotic divisions in
a shared cytoplasm, relying on mater-
nal stockpiles of RNA and proteins.
Stage 10 follicle cells are shown in
gray, germline and early embryo cyto-
plasm in pink, and nuclei in red. Double arrows between (A) and (B) represent egg chamber development and oocyte meiotic maturation at stage
13. Double arrows between (B) and (C) represent completion of meiosis (upon egg activation) and fertilization. DAPI-stained DNA from a stage 10
oocyte arrested in prophase I (A9), a stage 14 oocyte in early (B9) or late (B99) metaphase I, and from early embryonic nuclei in interphase (C9)o r
mitosis (C99) are shown below corresponding diagrams. Scale bar, 5 mm.
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fragment with the GFP coding sequence fused immediately upstream
of and in frame with the polo coding region (Moutinho-Santos et al.
1999). Balancer chromosomes and other genetic elements are de-
scribed in FlyBase (http://ﬂybase.org).
For measurement of embryo hatch rates, females of various
genotypes were crossed to ywmales, and embryos collected overnight.
For most genotypes, 100 to 150 collected embryos were placed in
groups of 10 on molasses plates containing a small amount of wet
yeast in their center. (For genotypes displaying low rates of egg laying,
fewer embryos were collected.) Plates were incubated in a humid
chamber at 25  for 2 d, and unhatched embryos were counted and
subtracted from the total to determine the hatch rate as a percentage.
Experiments were performed in triplicate, and statistical analysis was
performed using the Student’s t test.
Deﬁciency screen
To identify deﬁciencies that lead to female sterility or lethality of
endos00003/+ heterozygotes, or endos00003 dominant enhancers, we per-
formed an F1 screen (supporting information, Figure S1). endos00003/
TM3, Sb1 virgin females were crossed to males carrying 208 balanced
deﬁciencies (Df; File S1) and progeny were analyzed. (We estimate
that these deﬁciencies represent roughly 45% genome coverage be-
cause the entire Deﬁciency Kit from the Bloomington Stock Center
contains 469 deﬁciencies, which together provide 98% coverage of the
genome.) If no adult endos00003/Df or Df/+; endos00003/+ ﬂies resulted
from the cross (i.e., only ﬂies carrying balancer chromosomes were
present among progeny), the genetic interaction was considered lethal.
Otherwise, four endos00003/Df or Df/+; endos00003/+ females were
crossed to three ywmales to test their fertility. If these females yielded
drastically reduced or no progeny, the genetic interaction was consid-
ered semisterile or sterile, respectively. Only deﬁciencies that yielded
reproducible results as endos00003/+ enhancers in triplicate experi-
ments were added to the ﬁnal list of enhancer deﬁciencies. For each
interacting genomic region identiﬁed through the deﬁciency screen,
additional deﬁciencies were tested as shown in Table S1 and Table S3.
Western blotting
For Western blotting analyses, ovaries or egg chambers were homog-
enized, electrophoresed, and transferred to membranes as described
(Von Stetina et al. 2008). Membranes were blocked and probed with
1:500 guinea pig polyclonal anti-Mtrm (Xiang et al. 2007), 1:4,000 rat
monoclonal anti-a-tubulin (YL1/2, Accurate Chemical & ScientiﬁcC o r -
poration), or 1:50 mouse monoclonal anti-Actin (JLA20, Developmen-
tal Studies Hybridoma Bank). IRDye 800-conjugated goat anti-guinea
pig (Rockland) or horseradish peroxidase-conjugated goat anti-rabbit,
donkey anti-guinea pig, or goat anti-rat (Jackson ImmunoResearch
Laboratories) secondary antibodies were used at 1:5000 or 1:4000 dilu-
tions. The Odyssey Infrared Imaging System (LI-COR Biosciences) or
enhanced chemiluminescence (Amersham Life Science) was used for
detection.
Immunostaining and ﬂuorescence microscopy
Egg chamber staging and analysis of oocyte meiotic maturation were
performed as described (Von Stetina et al. 2008), with some modiﬁ-
cations. In brief, ovaries were dissected, ﬁxed, and stained in 0.5 mg/ml
49,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) for 20 min.
Analysis of DNA and spindles in early embryonic mitoses were per-
formed essentially as described (Von Stetina et al. 2008). In brief, 0- to
60-min embryos were collected, dechorionated, shaken vigorously for
2 min in 1:1 heptane:methanol, ﬁxed in methanol overnight, and
stained with anti-a-tubulin FITC-conjugated antibody (DM1A clone;
Sigma-Aldrich) at 1:300 dilution and 0.5 mg/ml DAPI or 10 mg/ml
propidium iodide following RNAse A treatment. Samples mounted in
Vectashield (Vector Laboratories) were imaged with a Zeiss Axioplan 2
or AxioImager-A2 ﬂuorescence microscope, or LSM700 confocal mi-
croscope. For statistical analysis, results were subjected to the Yates’
chi-square test (x2= S(jO-Ej2 1/2)2/ E) (Yates 1934).
RESULTS
Ad e ﬁciency screen for dominant enhancers of endos
heterozygosity identiﬁes multiple interacting
genomic regions
The small phosphoprotein Endos has critical biological roles in Dro-
sophila oocyte meiotic maturation and early embryonic mitoses (Von
Stetina et al. 2008). Although the molecular mechanisms of action of
Endos during cell cycle regulation are likely complex, recent biochem-
ical studies uncovering an in vitro role for the Xenopus homolog as
a stoichiometric binding inhibitor of protein phosphatase 2A (Gharbi-
Ayachi et al. 2010; Mochida et al. 2010) suggest that the gene dosage
of endos might be relevant for its roles in the cell cycle. It is therefore
conceivable that although endos00003/+ heterozygous females are
largely phenotypically normal (Drummond-Barbosa and Spradling
2004), removal of one copy of other genes that function together with
endos in the regulation of meiotic maturation and/or early embryonic
mitoses might genetically enhance endos00003, resulting in sterility or
semisterility of those females. We performed an F1 screen for
enhancers of endos00003 heterozygous females using 208 deﬁciencies
( 45% genome coverage) from the Bloomington Stock Center De-
ﬁciency Kit (Figure S1 and File S1). As expected, Df(3L)fz-GF3b,
which uncovers the endos gene itself, led to complete female sterility
in combination with endos00003. We also found 11 additional deﬁcien-
cies that impair the fertility of endos00003 heterozygous females (Figure
2 and Table 1), and for all of the regions uncovered by these interact-
ing deﬁciencies (except for Df(3L)BSC815; see below) additional deﬁ-
ciencies were tested to reﬁne the results (Table S1).
Our screen also revealed a zygotic role for endos. Speciﬁcally, ﬁve
deﬁciencies led to zygotic lethality of endos00003 heterozygotes during
development (Figure 2 and Table S2), and additional deﬁciencies
uncovering the identiﬁed interacting regions were also tested (Table
S3). These results are consistent with a recent study that showed that
endos function is zygotically required for proper neuroblast cell cycles
during Drosophila development (Rangone et al. 2011).
endos and mtrm are strong genetic interactors
Df(3L)BSC815, which removes region 66C3266D4, drastically re-
duced the fertility of endos00003/+ heterozygous females, with hatch
rates of 26% for embryos produced by these females (Table 1). Region
66C3266D4 contains matrimony (mtrm), a gene previously reported
to encode a negative regulator of Polo kinase that controls the timing
of meiotic maturation and chromosome segregation in a dose-sensi-
tive manner. Females that are heterozygous for the null mtrm126 allele
display premature nuclear envelope breakdown (a hallmark of meiotic
maturation) and increased frequencies of X and 4th chromosome
nondisjunction, and these phenotypes are completely suppressed by
removal of one copy of polo (Xiang et al. 2007). To test whether the
interaction between endos00003 and Df(3L)BSC815 was caused by the
loss of one copy of mtrm,w eg e n e r a t e dmtrm126 +/+ endos00003
females. Indeed, the fertility of these double heterozygous females
was signiﬁcantly reduced relative to the fertility of mtrm126/+ or
endos00003/+ single heterozygous females (see Figure 4A).
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The reduced fertility of mtrm126 +/+ endos00003 females could result
from defects in oocyte meiosis, early embryonic mitoses, or a combi-
nation of both. endos00003 homozygous females have a prolonged pro-
phase I arrest, and Endos positively regulates Polo protein expression
levels (Von Stetina et al. 2008). mtrm126/+ heterozygous females have
premature meiotic maturation, and Mtrm binds to Polo and inhibits
its activity (Xiang et al. 2007). Analyzing DNA morphology as pre-
viously described (Von Stetina et al. 2008; see Figure 1), we observed
that a small but signiﬁcant percentage of oocytes from mtrm126/+
females are released from the prophase I arrest slightly prematurely
(see “Early St. 13” in Figure 3A); this result is consistent with but not
as pronounced as previously reported (Xiang et al. 2007). Conversely,
af r a c t i o no fendos00003/+ heterozygous oocytes shows prolonged pro-
phase I arrest (see “Mid St. 13” in Figure 3A); this phenotype is in
agreement with the more severe prolongation of prophase I in
endos00003 homozygotes (Von Stetina et al. 2008). mtrm126 +/+
endos00003 double heterozygotes show an intermediate phenotype,
with some oocytes leaving prophase I slightly prematurely and others
remaining in prophase I longer (Figure 3A).
endos00003 homozygous females do not progress to metaphase I
and show a dispersed DNA morphology in stage 14 oocytes (Von
Stetina et al. 2008), and mtrm126/+ heterozygous stage 14 oocytes have
mispositioned chromosomes, resulting in a high frequency of non-
disjunction (Xiang et al. 2007). We therefore also examined genetic
interactions between endos and mtrm in stage 14 oocytes. The vast
majority of control and endos00003/+ heterozygous oocytes displayed
typical metaphase I morphology (Figure 3, B and C; also see Figure
1B9,B 99). mtrm126/+ heterozygotes displayed a high frequency of
oocytes containing misarranged chromosome masses (Figure 3, B
and D), consistent with reported non-disjunction defects (Xiang
et al. 2007). Removal of one copy of endos did not suppress or en-
hance the abnormal stage 14 DNA morphology of mtrm126/+ hetero-
zygous oocytes (Figure 3, B and E). Taken together, these results
suggest that endos00003 and mtrm126 do not have signiﬁcant genetic
interactions during meiotic maturation.
Maternal endos and mtrm dominantly interact to
control early embryonic mitoses
As described previously, the fertility of mtrm126 +/+ endos00003 double-
heterozygous females is markedly reduced relative to that of single
heterozygotes. In accordance, embryos produced by mtrm126 +/+
endos00003 females have a very reduced hatch rate (1.3%) relative to
those produced by ywcontrol (90%), endos00003 heterozygous (94%),
or mtrm126 heterozygous (74%) females (Figure 4A). Because meiosis
does not appear to be signiﬁcantly disrupted in double heterozygotes
(Figure 3), we instead examined the early mitoses of embryos laid by
these females (Figure 4, B–D). Most of the embryos laid by ywcontrol
(91%) or endos00003 heterozygous (95%) females had normal DNA
and spindle morphology (Figure 4, B and C). A sizeable fraction of
embryos from mtrm126 heterozygous females had DNA morphology
Figure 2 Chromosomal distribution of
deﬁciencies that dominantly enhance
endos00003/+. Gray bars depict chro-
mosome arms (X, 2L, 2R, 3L, and 3R),
and black numbers indicate polytene
chromosome divisions. Deﬁciencies
shown in red dominantly cause sterility
or semisterility of endos00003 heterozy-
gous females, whereas those shown
in blue dominantly cause lethality of
endos00003 heterozygous animals.
Red and blue bars above deﬁciency
indicate their deleted genomic regions
according to FlyBase (http://ﬂybase.
org). Asterisk indicates endos location.
n Table 1 Deﬁciencies that reduce the fertility of endos00003/+
heterozygous females
Deﬁciency Deleted segmenta Hatch rateb
Df(1)JC70 4C11—5A4 21 6 11 (416)
Df(2L)J2 31B1—32A2 n.d.
Df(2R)X1 46C2—47A1 n.d.
Df(2R)CX1 49C1—50D5 41 6 2.0 (300)
Df(2R)BSC11 50E6—51E4 3.3 6 3.2 (300)
Df(3L)BSC815c 66C3—66D4 26 6 3.6 (317)
Df(3L)fz-GF3bd 70C2—70D5 0 6 0 (344)
Df(3R)WIN11 83E1—84A5 53 6 9.9 (21)e
Df(3R)Scr 84A1—84B2 n.d.
Df(3R)by10 85D8—85E13 26 6 27 (243)
Df(3R)BSC43 92F7—93B6 94 6 8.5 (54)e
Df(3R)23D1 94A3—94D4 46 6 5.7 (298)
a
Deleted genomic region represented according to polytene chromosome
divisions (http://ﬂybase.org).
b
Percentage of embryos from endos00003/Df or Df/+; endos00003/+ females
that hatch. Results from three or four experiments shown as mean 6 SD.
The total number of embryos analyzed is shown in parentheses.
c
Df(3L)BSC815 uncovers mtrm.
d
Df(3L)fz-GF3b uncovers endos.
e
Females lay very few eggs, which contributes to their reduced fertility.
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Figure 4B), consistent with the slightly reduced hatch rate of these
embryos (Figure 4A). Early mitosis defects, however, were signiﬁ-
cantly more severe in embryos derived from mtrm126 +/+ endos00003
double-heterozygous females (only 19% normal; Figure 4, B and
D2G). These results indicate that mtrm and endos genetically interact
in the maternal control of early embryonic mitoses.
endos and mtrm have distinct effects on Polo. endos00003 homozy-
gous females have reduced levels of Polo expression in stage 14
oocytes (Von Stetina et al. 2008), and Mtrm is thought to bind to
Polo stoichiometrically and inhibit its activity (Xiang et al. 2007). The
effect of mtrm on polo function is dosage sensitive because mtrm126/+
heterozygous females have increased meiotic nondisjunction, and this
phenotype is rescued by removal of one copy of polo and partially
phenocopied by an extra copy of polo (Xiang et al. 2007). Accordingly,
halving the dosage of polo also suppresses the decreased hatch rates
of embryos derived from mtrm126/+ heterozygous females (Figure 4).
We therefore reasoned that the strong genetic interaction between
endos and mtrm during early embryonic mitoses might result from
alterations in polo function. Indeed, removal of one copy of polo
(polo16-1/+) in mtrm126 +/+ endos00003 double-heterozygous females
completely restored normal embryonic hatch rates and early mitoses
(Figure 4, A, B, and H), whereas introducing one extra copy of polo
(GFP::polo; +/+) resulted in very low hatch rates of embryos from
both mtrm126/+ and mtrm126 +/+ endos00003 females (Figure 4, A and
B). These results provide strong genetic evidence to support the model
that early embryos produced by mtrm126 +/+ endos00003 females have
abnormally high Polo activity, leading to abnormal mitoses.
Endos regulates the levels of Mtrm maternally loaded
into the early embryo
Our observations that maternal mtrm interacts with endos to control
early embryonic mitoses were initially surprising because Mtrm ex-
pression had been reported to be greatly reduced by stage 13 of
oogenesis, based on immunoﬂuorescence assays (Xiang et al. 2007).
Because antibody penetration often presents a challenge for immuno-
ﬂuorescence detection in later stages of oogenesis, we examined Mtrm
expression by Western blotting analyses of staged egg chambers. In
ywcontrol females, Mtrm is very highly expressed in stages 13 and 14
of oogenesis (Figure 5A). The band recognized by the antibody indeed
corresponds to Mtrm, as it is not present in mtrm126 homozygous
stage 14 oocytes (Figure 5B). These results indicate that Mtrm protein
is maternally loaded into early embryos.
Removal of one copy of endos strongly enhances the early mitosis
defects of embryos produced by mtrm126/+ heterozygotes (see Figure
4), and Endos regulates the levels of several cell-cycle regulators in
mature oocytes, including Polo, Twine (Twe), and Cyclin A (Von
Stetina et al. 2008; J. R. Von Stetina and D. Drummond-Barbosa,
unpublished data). We therefore tested whether endos might control
the expression of Mtrm during oogenesis. In endos00003 homozygous
females, Mtrm levels in earlier stages of egg chamber development are
comparable with those of controls. In contrast, endos00003 homozygous
stage 13 and 14 oocytes show markedly reduced levels of Mtrm (Fig-
ure 5, A and B).
Endos and Elgi, a predicted E3 ubiquitin ligase, physically interact
in vitro, and antagonize each other in vivo (Von Stetina et al. 2008).
Although elgi is not involved in the degradation of Polo or Twe (Von
Stetina et al. 2008), we tested whether Elgi might control Mtrm levels.
elgi1 homozygous females, however, did not have increased levels of
Mtrm in stages 13 and 14 (Figure 5, A and B). These results suggest
that Elgi is not a major regulator of Mtrm levels in mature oocytes and
that endos likely regulates Mtrm levels via a separate pathway. Indeed,
we observed a reduction in Mtrm levels in oocytes of females mutant
for twe (twe1; Figure 5A), which encodes a positive regulator of Cdk1,
suggesting that the effects of endos on Mtrm expression might at least
in part be a consequence of reduced phosphorylation of Cdk1 sub-
strates. Based on our data, we speculate that mtrm126 +/+ endos00003
double heterozygous females have sufﬁcient Polo expression to com-
plete meiosis. However, the lower mtrm gene dosage combined with
the further reduction in Mtrm expression caused by endos heterozy-
gosity substantially reduces the levels of this dose-sensitive stoichio-
metric regulator of Polo, leading to abnormally high Polo activity
levels and severe early mitoses defects (Figure 5C).
DISCUSSION
We had previously identiﬁed endos as a key regulator of meiotic
maturation and early embryonic mitoses (Von Stetina et al. 2008),
and our genetic screen in this study identiﬁed several genomic inter-
vals that dominantly interact with endos00003/+ to produce strong
sterility or viability defects. These results suggest that endos plays
Figure 3 endos and mtrm do not show genetic inter-
actions during oocyte meiosis. (A) Quantiﬁcation of per-
centage of oocytes remaining in prophase I at stages
12, early 13, mid 13, and late 13 and 14 of oogenesis.
Numbers of oocytes analyzed for ywcontrol,
endos00003/+, mtrm126/+, and mtrm126 +/+ endos00003
are as follows, respectively. Stage 12: 69, 56, 68, 41;
early stage 13: 101, 163, 171, 109; mid stage 13: 27,
92, 65, 61; late stage 13: 128, 247, 189, 265; stage 14:
106, 239, 312, 773. (B) Quantiﬁcation of percentage
of stage 14 oocytes showing abnormal DNA morphol-
ogy. Numbers of oocytes analyzed for ywcontrol,
endos00003/+, mtrm126/+, and mtrm126 +/+ endos00003
are 106, 239, 312, and 773, respectively.  P ¼ 0.002.
  P ¼ 0.0005.    P ¼ 1 · 10214. ns, no signiﬁcant differ-
ence. (C–E) Examples of stage 14 oocyte DNA morphol-
ogy for control (C, normal), mtrm126 (D, abnormal) and
mtrm126 +/+ endos00003 (E, abnormal). Scale bar, 5 mm.
Volume 1 December 2011 | endos and mtrm in the Cell Cycle | 611multiple roles during the cell cycle throughout development and that
its effects are complex and dosage dependent. Evidence from its ver-
tebrate homolog (Gharbi-Ayachi et al. 2010; Mochida et al. 2010)
suggests that Endos may act as a small regulatory protein that
represses PP2A to promote entry into mitosis and meiotic maturation,
and a recent study provides genetic support for this model in Dro-
sophila (Rangone et al. 2011). It is conceivable that Endos binds
additional cell cycle proteins to modulate their activity in a similar
fashion.
We uncovered mtrm, which encodes a stoichiometric inhibitor of
Polo kinase, as a strong dominant enhancer of endos. Double hetero-
zygosity of endos and mtrm induced severe sterility mostly as the result
of defects in early embryonic mitoses. By reducing the gene dosage
of polo we completely rescued the fertility defects of mtrm126 +/+
endos00003 females, indicating that the primary cause of this steril-
ity phenotype is excessive Polo activity. Although we previously
showed that Endos positively controls Polo protein levels during
meiosis (Von Stetina et al. 2008), these data suggest that later,
during early embryonic mitoses, maternal endos antagonizes Polo
activity through its effects on Mtrm expression during oocyte de-
velopment (Figure 5C). We thus propose that Endos is required
during late stages of oogenesis to promote high levels of Mtrm
protein to be loaded into early embryos for the proper stoichio-
metric balance between Mtrm and Polo, which is essential for
normal mitoses in early embryogenesis (Figure 5C).
The early syncytial embryo is particularly sensitive to the balance
between speciﬁc cell-cycle regulators. For example, a balance between
Gwl kinase and Polo activities has been proposed to be crucial for
early embryonic mitoses (Archambault et al. 2007). Embryos derived
Figure 5 endos is required for maternal expression of Mtrm. (A) West-
ern blot showing Mtrm protein expression at different stages of
oogenesis in ywcontrol, endos00003, twe1,o relgi1 homozygous
females. g-St. 11, germarium through stage 11; St. 12, stage 12; St.
13, stage 13; St. 14, stage 14. Actin was used as a loading control. One
hundred egg chambers (or g-St.11 sets) were loaded per lane. (B)
Mtrm Western blot of ywcontrol, mtrm126, endos00003, and elgi1 stage
14 oocytes. Tubulin was used as a loading control. We were unable to
examine Mtrm levels in elgi1 endos00003 double homozygous females
due to the poor health of this genotype. (C) Model for genetic inter-
action between endos and mtrm. In wild-type females (Control), Endos
promotes expression of Mtrm, a known negative regulator of Polo,
during oogenesis resulting in normal levels of Polo function in the early
embryo. In mtrm126/+ heterozygous females, reduced levels of mater-
nal Mtrm loaded into the embryo lead to increased Polo activity and
abnormal embryonic mitoses. Removal of one copy of endos in
mtrm126 +/+ endos00003 double heterozygous females results in early
embryos with further reduced levels of Mtrm, leading to even higher
levels of Polo activity and more severe defects during early embryonic
mitoses.
Figure 4 endos and mtrm show dominant genetic interactions during
early embryonic mitoses. (A) Hatch rates for embryos derived from yw
control, endos00003/+, mtrm126/+,o rmtrm126 +/+ endos00003 females
in wild-type (2 copies of polo), polo16-1/+ (one copy of polo)o rGFP::
polo (three copies of polo) background. Three hundred embryos were
analyzed per genotype. a vs. a, P ¼ 2.8 · 1027.bvs. b, P ¼ 6.8 ·
10276.cvs. c, P ¼ 2.1 · 10212.dvs. d, P ¼ 2.5 · 10278.evs. e, P ¼
4.3 · 102106. (B) Quantiﬁcation of percentage of nuclei from embryos
derived from ywcontrol, endos00003/+, mtrm126/+,o rmtrm126 +/+
endos00003,o rmtrm126 + polo16-1/+ endos00003 + females displaying
normal or defective DNA and spindle morphology. In addition to mis-
aligned DNA, other defects include attached spindles, highly con-
densed DNA, or no mitotic nuclei with two rosettes present.
Numbers of nuclei (n) analyzed are shown above bars. Ten to ﬁfteen
embryos were analyzed for each genotype. (C–H) Examples of yw
control embryo nucleus with normal DNA morphology (C), or nuclei
from embryos produced by mtrm126 +/+ endos00003 female showing
misaligned DNA and abnormal spindle (D, E) or highly condensed and
disorganized DNA (F,G), and normal nucleus from embryo produced
by mtrm126 + polo16-1/+ endos00003 + female (H) are shown. Scale bar,
5 mm.
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active allele of gwl, are not viable because of a signiﬁcant loss or
detachment of centrosomes, and this phenotype is rescued by in-
creased maternal polo dosage. These studies led to the conclusion that
excessive Gwl activity relative to Polo results in defects in the early
syncytial embryo. Interestingly, the authors proposed that phosphor-
ylation of an intermediate substrate by Gwl mediates its inhibitory
effect since Gwl does not phosphorylate Polo (Archambault et al.
2007). Given that vertebrate Endos is phosphorylated and activated
by Gwl (Gharbi-Ayachi et al. 2010; Mochida et al. 2010), and this also
appears to be the case in Drosophila (Rangone et al. 2011), it is
tempting to speculate that Gwl acts upstream of Endos to control
Mtrm expression during late oogenesis and thereby antagonizes Polo
in the early embryo.
Endos controls the expression of multiple key regulators of the cell
cycle, including Polo, Twe/Cdc25, and Cyclin A (Von Stetina et al.
2008; J. R. Von Stetina and D. Drummond-Barbosa, unpublished
data), and in this study we found that Mtrm expression also requires
endos function. Although it is formally possible that Endos might
control the expression of other proteins via the predicted E3 ubiquitin
ligase Elgi, Elgi does not appear to mediate the degradation of Polo,
Twe or Mtrm in endos mutant females. Instead, it is conceivable that
endos might regulate the activity of the anaphase-promoting complex/
cyclosome (APC/C), which controls the degradation of multiple
cell-cycle regulators (Peters 2006). Future studies should address
functional interactions between the anaphase-promoting complex/
cyclosome and endos.
Our data uncovering a zygotic role for endos suggests that it may
not only function during meiosis or specialized S-M early embryonic
mitoses but also act as a general regulator of the cell-cycle machinery.
This idea is consistent with a recent study showing that endos is
zygotically required during Drosophila development for neuroblast
proliferation (Rangone et al. 2011), and with the recently identiﬁed
roles for endos in chromosome alignment and spindle assembly
(Goshima et al. 2007), the G2-M DNA damage checkpoint (Kondo
and Perrimon 2011), and with the PP2A inhibitory function of ver-
tebrate Endos (Gharbi-Ayachi et al. 2010; Mochida et al. 2010). The
molecular identiﬁcation of the speciﬁc genes interacting with endos in
both sterile and lethal combinations will help us better understand
how Endos controls the cell-cycle machinery and how Endos is reg-
ulated during the cell cycle. Based on the evolutionary conservation of
Endos and its cell-cycle functions, this knowledge will likely be of
broad relevance.
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